Clinical Trial Update: Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rectal misoprostol to reduce intra-operative blood loss during myomectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Misoprostol (rectal) (misoprostol)

Snippet

Sponsor: Pak Emirates Military Hospital | Conditions: Blood Loss, Surgical, Uterine Myoma | Phase 3 | Status: COMPLETED